ÂÜÀòÂÒÂ×

Mr. Mihalik has a combined 40 years of experience in the pharmaceutical and biomedical industries. He most recently served as the Senior Vice President, Sales and Marketing, and Chief Commercial Officer of Amylin Pharmaceuticals. Prior to joining Amylin, he was Vice President Global Brand Development and Commercialization for the Diabetes and Endocrine Platform at Eli Lilly. From 1998 to 2001, he served as Senior Vice President and General Manager for Lab Systems and Molecular Biochemicals at Roche Diagnostics. From 1990 to 1998, he served in various management capacities at Boehringer Mannheim including, President Diabetes Care North America. Prior to this he held various positions of increasing responsibility at American Hospital Supply Corporation (AHSC) and Baxter Healthcare, after the latter acquired AHSC in 1985. His final roles being that of President and General Manager of the Pandex R&D division of Baxter. He holds a B.S. degree in Biology from Pennsylvania State University and a Masters in Management from Northwestern University.